Imunon, Inc. (IMNN)

USD 0.97

(-3.0%)

Total Assets Summary of Imunon, Inc.

  • Imunon, Inc.'s latest annual total assets in 2023 was 21.91 Million USD , down -50.16% from previous year.
  • Imunon, Inc.'s latest quarterly total assets in 2024 Q1 was 14.32 Million USD , down -34.64% from previous quarter.
  • Imunon, Inc. reported annual total assets of 43.97 Million USD in 2022, down -40.61% from previous year.
  • Imunon, Inc. reported annual total assets of 74.04 Million USD in 2021, up 97.31% from previous year.
  • Imunon, Inc. reported quarterly total assets of 9.69 Million USD for 2024 Q2, down -32.34% from previous quarter.
  • Imunon, Inc. reported quarterly total assets of 21.91 Million USD for 2023 Q4, down -11.1% from previous quarter.

Annual Total Assets Chart of Imunon, Inc. (2023 - 1996)

Historical Annual Total Assets of Imunon, Inc. (2023 - 1996)

Year Total Assets Total Assets Growth
2023 21.91 Million USD -50.16%
2022 43.97 Million USD -40.61%
2021 74.04 Million USD 97.31%
2020 37.52 Million USD -1.96%
2019 38.27 Million USD -18.31%
2018 46.85 Million USD -1.39%
2017 47.51 Million USD 54.02%
2016 30.84 Million USD -37.11%
2015 49.05 Million USD -26.45%
2014 66.69 Million USD 46.03%
2013 45.67 Million USD 80.1%
2012 25.35 Million USD -22.33%
2011 32.64 Million USD 1192.92%
2010 2.52 Million USD -82.94%
2009 14.8 Million USD -37.5%
2008 23.68 Million USD -39.32%
2007 39.03 Million USD 106.23%
2006 18.92 Million USD 18.98%
2005 15.9 Million USD -6.7%
2004 17.05 Million USD 29.89%
2003 13.12 Million USD 472.93%
2002 2.29 Million USD -22.5%
2001 2.95 Million USD -67.57%
2000 9.11 Million USD 469.86%
1999 1.6 Million USD 383.77%
1998 330.73 Thousand USD -59.82%
1997 823.2 Thousand USD -91.17%
1996 9.32 Million USD 0.0%

Peer Total Assets Comparison of Imunon, Inc.

Name Total Assets Total Assets Difference
AbCellera Biologics Inc. 1.48 Billion USD 98.527%
Alkermes plc 2.13 Billion USD 98.974%
Agenus Inc. 313.91 Million USD 93.018%
Alnylam Pharmaceuticals, Inc. 3.82 Billion USD 99.428%
Aptorum Group Limited 20.64 Million USD -6.192%
Ardelyx, Inc. 297.57 Million USD 92.635%
Arrowhead Pharmaceuticals, Inc. 765.55 Million USD 97.137%
Bicycle Therapeutics plc 595.34 Million USD 96.318%
BioXcel Therapeutics, Inc. 73.7 Million USD 70.261%
ChromaDex Corporation 54.96 Million USD 60.123%
Chimerix, Inc. 212.77 Million USD 89.699%
Corbus Pharmaceuticals Holdings, Inc. 28.27 Million USD 22.475%
Caribou Biosciences, Inc. 440.96 Million USD 95.03%
CRISPR Therapeutics AG 2.22 Billion USD 99.017%
Precision BioSciences, Inc. 159.78 Million USD 86.282%
Dyadic International, Inc. 8.21 Million USD -166.668%
Eton Pharmaceuticals, Inc. 31.74 Million USD 30.945%
Fortress Biotech, Inc. 167.52 Million USD 86.917%
Lantern Pharma Inc. 43.64 Million USD 49.784%
HOOKIPA Pharma Inc. 161.33 Million USD 86.415%
Inhibikase Therapeutics, Inc. 14.5 Million USD -51.09%
Incyte Corporation 6.78 Billion USD 99.677%
IO Biotech, Inc. 150.71 Million USD 85.458%
Jaguar Health, Inc. 50.76 Million USD 56.823%
Novavax, Inc. 1.85 Billion USD 98.819%
Janux Therapeutics, Inc. 380.4 Million USD 94.238%
Opthea Limited 188.79 Million USD 88.39%
Ligand Pharmaceuticals Incorporated 833.06 Million USD 97.369%
ContextLogic Inc. 423 Million USD 94.818%
MiMedx Group, Inc. 239.04 Million USD 90.831%
Pyxis Oncology, Inc. 173.72 Million USD 87.384%
TransCode Therapeutics, Inc. 5.16 Million USD -323.972%
NextCure, Inc. 129.41 Million USD 83.064%
Ocuphire Pharma, Inc. 53.94 Million USD 59.372%
Oncternal Therapeutics, Inc. 36.72 Million USD 40.325%
Outlook Therapeutics, Inc. 32.3 Million USD 32.144%
Vaxcyte, Inc. 1.4 Billion USD 98.443%
PDS Biotechnology Corporation 59.39 Million USD 63.095%
Madrigal Pharmaceuticals, Inc. 640.54 Million USD 96.578%
Pharming Group N.V. 462.85 Million USD 95.265%
Pieris Pharmaceuticals, Inc. 38.68 Million USD 43.335%
Avidity Biosciences, Inc. 628.55 Million USD 96.513%
Reviva Pharmaceuticals Holdings, Inc. 18.92 Million USD -15.824%
Reviva Pharmaceuticals Holdings, Inc. 18.92 Million USD -15.824%
Sangamo Therapeutics, Inc. 165.32 Million USD 86.742%
Sol-Gel Technologies Ltd. 45.28 Million USD 51.602%
Acelyrin, Inc. 742.69 Million USD 97.049%
Salarius Pharmaceuticals, Inc. 6.58 Million USD -232.771%
SELLAS Life Sciences Group, Inc. 6.4 Million USD -242.309%
Summit Therapeutics Inc. 202.94 Million USD 89.2%
Sensei Biotherapeutics, Inc. 74.37 Million USD 70.53%
Senti Biosciences, Inc. 119.48 Million USD 81.656%
Stoke Therapeutics, Inc. 228.34 Million USD 90.401%
Syros Pharmaceuticals, Inc. 168.17 Million USD 86.967%
Alaunos Therapeutics, Inc. 8.26 Million USD -165.256%
Telomir Pharmaceuticals, Inc. Common Stock 4.77 Million USD -359.136%
Entrada Therapeutics, Inc. 469.19 Million USD 95.329%
VistaGen Therapeutics, Inc. 123.65 Million USD 82.275%
Wave Life Sciences Ltd. 274.94 Million USD 92.028%
Sorrento Therapeutics, Inc. 472.84 Million USD 95.365%
TRACON Pharmaceuticals, Inc. 10.1 Million USD -116.903%
Barinthus Biotherapeutics plc 214.5 Million USD 89.782%
Psyence Biomedical Ltd. 1.13 Million USD -1835.953%
Phathom Pharmaceuticals, Inc. 413.84 Million USD 94.704%
Immix Biopharma, Inc. 19.92 Million USD -10.002%
Keros Therapeutics, Inc. 370.02 Million USD 94.077%
MEI Pharma, Inc. 41.37 Million USD 47.026%
Windtree Therapeutics, Inc. 32.4 Million USD 32.364%
Xeris Biopharma Holdings, Inc. 340.79 Million USD 93.569%
Rigel Pharmaceuticals, Inc. 117.22 Million USD 81.303%
Fortress Biotech, Inc. 167.52 Million USD 86.917%
Precigen, Inc. 151.04 Million USD 85.489%
Clearside Biomedical, Inc. 34.01 Million USD 35.569%
AlloVir, Inc. 190.79 Million USD 88.512%
C4 Therapeutics, Inc. 376.45 Million USD 94.178%
Fate Therapeutics, Inc. 506.21 Million USD 95.67%
ImmuCell Corporation 43.8 Million USD 49.968%
IDEAYA Biosciences, Inc. 649.31 Million USD 96.624%
Onconetix, Inc. 88.82 Million USD 75.323%
PureTech Health plc 693.97 Million USD 96.842%
VYNE Therapeutics Inc. 97.68 Million USD 77.563%
Elevation Oncology, Inc. 89.09 Million USD 75.398%
Kintara Therapeutics, Inc. 6.2 Million USD -253.403%
Seer, Inc. 436.26 Million USD 94.976%
Verrica Pharmaceuticals Inc. 81.59 Million USD 73.139%
Innoviva, Inc. 1.24 Billion USD 98.237%
Aadi Bioscience, Inc. 132.42 Million USD 83.448%
ESSA Pharma Inc. 149.12 Million USD 85.302%
GlycoMimetics, Inc. 45.31 Million USD 51.633%
GT Biopharma, Inc. 14.1 Million USD -55.348%
Inhibrx Biosciences, Inc. 307.89 Million USD 92.881%
Akebia Therapeutics, Inc. 241.7 Million USD 90.932%
Catalyst Pharmaceuticals, Inc. 471.9 Million USD 95.355%
Longboard Pharmaceuticals, Inc. 50.69 Million USD 56.767%
Orchestra BioMed Holdings, Inc. 95.21 Million USD 76.98%
Alzamend Neuro, Inc. 631.58 Thousand USD -3370.311%
Rocket Pharmaceuticals, Inc. 566.34 Million USD 96.13%
Aptose Biosciences Inc. 12.92 Million USD -69.611%
ZyVersa Therapeutics, Inc. 22.11 Million USD 0.887%
Soligenix, Inc. 9.79 Million USD -123.715%
Century Therapeutics, Inc. 360.69 Million USD 93.923%
Kura Oncology, Inc. 448.93 Million USD 95.118%
TScan Therapeutics, Inc. 272.14 Million USD 91.946%
Intensity Therapeutics, Inc. 17.29 Million USD -26.731%
Ocean Biomedical, Inc. 110.91 Million USD 80.238%
CytomX Therapeutics, Inc. 205.15 Million USD 89.316%
Autolus Therapeutics plc 375.38 Million USD 94.161%
Mineralys Therapeutics, Inc. 251.63 Million USD 91.29%
EyePoint Pharmaceuticals, Inc. 355.18 Million USD 93.829%
Eterna Therapeutics Inc. 49.13 Million USD 55.389%
Adaptive Biotechnologies Corporation 661.13 Million USD 96.685%
GRI Bio, Inc. 2.95 Million USD -641.477%
Xenetic Biosciences, Inc. 10.6 Million USD -106.672%
Tenaya Therapeutics, Inc. 170.51 Million USD 87.146%
IGM Biosciences, Inc. 423.41 Million USD 94.823%
INmune Bio, Inc. 57 Million USD 61.548%
Heron Therapeutics, Inc. 222.5 Million USD 90.149%
SAB Biotherapeutics, Inc. 83.94 Million USD 73.889%
Pasithea Therapeutics Corp. 26.11 Million USD 16.077%
Entero Therapeutics, Inc. 6.88 Million USD -218.429%
Milestone Pharmaceuticals Inc. 75.22 Million USD 70.864%
X4 Pharmaceuticals, Inc. 147.25 Million USD 85.116%
Atara Biotherapeutics, Inc. 165.5 Million USD 86.757%
Coherus BioSciences, Inc. 629.6 Million USD 96.519%
Verastem, Inc. 149.71 Million USD 85.36%
Abeona Therapeutics Inc. 64 Million USD 65.754%
Pliant Therapeutics, Inc. 512.15 Million USD 95.72%
Tonix Pharmaceuticals Holding Corp. 154.45 Million USD 85.81%
Histogen Inc. 19.07 Million USD -14.917%
Aprea Therapeutics, Inc. 22.65 Million USD 3.232%
Surrozen, Inc. 46.08 Million USD 52.435%
Organovo Holdings, Inc. 6.34 Million USD -245.221%
Lixte Biotechnology Holdings, Inc. 4.3 Million USD -408.703%
Ovid Therapeutics Inc. 144.02 Million USD 84.782%
Panbela Therapeutics, Inc. 11.8 Million USD -85.715%
CASI Pharmaceuticals, Inc. 75.26 Million USD 70.88%
Cadrenal Therapeutics, Inc. Common Stock 8.51 Million USD -157.277%
Centessa Pharmaceuticals plc 362.96 Million USD 93.961%
Hepion Pharmaceuticals, Inc. 18.09 Million USD -21.132%
Arcturus Therapeutics Holdings Inc. 429.4 Million USD 94.896%
BioRestorative Therapies, Inc. 12.61 Million USD -73.791%
Apollomics, Inc. 55.38 Million USD 60.427%
Amarin Corporation plc 831.68 Million USD 97.365%
Mesoblast Limited 669.15 Million USD 96.725%
Turnstone Biologics Corp. 112.81 Million USD 80.572%
Kymera Therapeutics, Inc. 575.75 Million USD 96.193%
Synaptogenix, Inc. 31.11 Million USD 29.555%
Tiziana Life Sciences Ltd 12.18 Million USD -79.892%
Aurinia Pharmaceuticals Inc. 548.06 Million USD 96.001%
BriaCell Therapeutics Corp. 5.87 Million USD -273.248%
Monopar Therapeutics Inc. 7.34 Million USD -198.402%
Exelixis, Inc. 2.94 Billion USD 99.255%
Better Therapeutics, Inc. 22.94 Million USD 4.467%
Nurix Therapeutics, Inc. 364.53 Million USD 93.987%
Apellis Pharmaceuticals, Inc. 788.73 Million USD 97.221%
NLS Pharmaceutics AG 1.84 Million USD -1086.916%
Dermata Therapeutics, Inc. 7.97 Million USD -174.71%
Aridis Pharmaceuticals, Inc. 14.69 Million USD -49.153%
Gritstone bio, Inc. 177.76 Million USD 87.67%
Jasper Therapeutics, Inc. 95.38 Million USD 77.02%
TNF Pharmaceuticals, Inc. 17.86 Million USD -22.706%
Avid Bioservices, Inc. 336.55 Million USD 93.488%
Insmed Incorporated 1.32 Billion USD 98.352%
Virpax Pharmaceuticals, Inc. 9.62 Million USD -127.641%
MediWound Ltd. 66.45 Million USD 67.02%
OmniAb, Inc. 401.98 Million USD 94.548%
Alector, Inc. 621.82 Million USD 96.475%
Seres Therapeutics, Inc. 358.6 Million USD 93.888%
Checkpoint Therapeutics, Inc. 5.37 Million USD -307.551%
Viracta Therapeutics, Inc. 56.69 Million USD 61.338%
Zai Lab Limited 1.03 Billion USD 97.885%
Revance Therapeutics, Inc. 478.45 Million USD 95.419%
Aura Biosciences, Inc. 255.07 Million USD 91.407%
Lyell Immunopharma, Inc. 750.02 Million USD 97.078%
Immunic, Inc. 54.29 Million USD 59.634%
Tarsus Pharmaceuticals, Inc. 266.22 Million USD 91.767%
Veracyte, Inc. 1.13 Billion USD 98.074%
InMed Pharmaceuticals Inc. 11.82 Million USD -85.388%
FibroGen, Inc. 423.52 Million USD 94.825%
SeaStar Medical Holding Corporation 3.51 Million USD -523.913%
Adial Pharmaceuticals, Inc. 4.73 Million USD -362.738%
Sonnet BioTherapeutics Holdings, Inc. 5.42 Million USD -303.686%
Jazz Pharmaceuticals plc 11.39 Billion USD 99.808%
Cyclacel Pharmaceuticals, Inc. 8.8 Million USD -148.928%
Amylyx Pharmaceuticals, Inc. 517.45 Million USD 95.764%
TG Therapeutics, Inc. 329.58 Million USD 93.35%
Galecto, Inc. 38.22 Million USD 42.663%
Calithera Biosciences, Inc. 28.67 Million USD 23.567%
Fortrea Holdings Inc. 4.35 Billion USD 99.497%
KalVista Pharmaceuticals, Inc. 235.4 Million USD 90.689%
Aptevo Therapeutics Inc. 24.84 Million USD 11.77%
XBiotech Inc. 227.24 Million USD 90.355%
Jasper Therapeutics, Inc. 95.38 Million USD 77.02%
Lyra Therapeutics, Inc. 142.6 Million USD 84.63%
Foghorn Therapeutics Inc. 285.91 Million USD 92.334%
Y-mAbs Therapeutics, Inc. 127.86 Million USD 82.859%
Theravance Biopharma, Inc. 381.99 Million USD 94.262%
Ultragenyx Pharmaceutical Inc. 1.49 Billion USD 98.53%
Metagenomi, Inc. Common Stock 364.84 Million USD 93.992%
Vaxxinity, Inc. 44.35 Million USD 50.583%
BioCryst Pharmaceuticals, Inc. 516.96 Million USD 95.76%
Gain Therapeutics, Inc. 18.6 Million USD -17.78%
Cartesian Therapeutics, Inc. 305.05 Million USD 92.815%
NexImmune, Inc. 8.59 Million USD -155.041%
Creative Medical Technology Holdings, Inc. 10.71 Million USD -104.551%
Marker Therapeutics, Inc. 17.12 Million USD -27.971%
Regeneron Pharmaceuticals, Inc. 33.08 Billion USD 99.934%
Chemomab Therapeutics Ltd. 22.15 Million USD 1.052%
Scopus BioPharma Inc. 392.26 Thousand USD -5487.567%
RAPT Therapeutics, Inc. 173.32 Million USD 87.355%
Ainos, Inc. 31.84 Million USD 31.166%
Pluri Inc. 39.52 Million USD 44.549%
Prothena Corporation plc 696.38 Million USD 96.853%
Adaptimmune Therapeutics plc 282.61 Million USD 92.245%
Celularity Inc. 143.88 Million USD 84.767%
Rallybio Corporation 115.62 Million USD 81.043%
Cue Biopharma, Inc. 61.53 Million USD 64.378%
MeiraGTx Holdings plc 458.16 Million USD 95.216%
Omeros Corporation 378.26 Million USD 94.206%
Humacyte, Inc. 128.22 Million USD 82.906%
Immunocore Holdings plc 597 Million USD 96.329%
Cocrystal Pharma, Inc. 31.25 Million USD 29.882%
Cidara Therapeutics, Inc. 68.53 Million USD 68.017%
Blueprint Medicines Corporation 1.04 Billion USD 97.911%
CalciMedica, Inc. 12.18 Million USD -79.877%
Cabaletta Bio, Inc. 253.65 Million USD 91.359%
Marinus Pharmaceuticals, Inc. 170.9 Million USD 87.176%
Scholar Rock Holding Corporation 311.03 Million USD 92.953%
Sana Biotechnology, Inc. 565.29 Million USD 96.123%
Pulmatrix, Inc. 33.95 Million USD 35.455%
Elicio Therapeutics, Inc. 27.14 Million USD 19.259%
Vigil Neuroscience, Inc. 140.85 Million USD 84.44%
Intellia Therapeutics, Inc. 1.3 Billion USD 98.315%
Adlai Nortye Ltd. American Depositary Shares 130.18 Million USD 83.164%
Cytokinetics, Incorporated 824.31 Million USD 97.341%
Eloxx Pharmaceuticals, Inc. 21.12 Million USD -3.764%
Nutriband Inc. 7.51 Million USD -191.574%
Protara Therapeutics, Inc. 78.95 Million USD 72.239%
Vor Biopharma Inc. 209.82 Million USD 89.554%
Roivant Sciences Ltd. 7.22 Billion USD 99.697%
Evogene Ltd. 51.1 Million USD 57.108%
ProKidney Corp. 420.55 Million USD 94.788%
Applied Therapeutics, Inc. 54.83 Million USD 60.028%
Hoth Therapeutics, Inc. 9.52 Million USD -130.225%
BridgeBio Pharma, Inc. 546.38 Million USD 95.988%
CorMedix Inc. 82.05 Million USD 73.29%
BioLineRx Ltd. 63.92 Million USD 65.713%
Tango Therapeutics, Inc. 402.56 Million USD 94.555%
Galectin Therapeutics Inc. 28.2 Million USD 22.276%
Atai Life Sciences N.V. 293.47 Million USD 92.532%
Renovaro Biosciences Inc. 163.12 Million USD 86.564%
Aerovate Therapeutics, Inc. 127.41 Million USD 82.798%
Zentalis Pharmaceuticals, Inc. 562.02 Million USD 96.1%
Sagimet Biosciences Inc. 96.71 Million USD 77.338%
MediciNova, Inc. 66.26 Million USD 66.926%
Praxis Precision Medicines, Inc. 87.94 Million USD 75.078%
Cardio Diagnostics Holdings, Inc. 4.46 Million USD -391.176%
GeoVax Labs, Inc. 9.28 Million USD -136.104%
Axsome Therapeutics, Inc. 588.23 Million USD 96.274%
Biomea Fusion, Inc. 199.92 Million USD 89.037%
PTC Therapeutics, Inc. 1.9 Billion USD 98.848%
Mereo BioPharma Group plc 66.49 Million USD 67.04%
Cullinan Oncology, Inc. 485.09 Million USD 95.482%
Syndax Pharmaceuticals, Inc. 612.88 Million USD 96.424%
Absci Corporation 234.48 Million USD 90.652%
NRx Pharmaceuticals, Inc. 7.31 Million USD -199.632%
4D Molecular Therapeutics, Inc. 339.89 Million USD 93.551%
Dyne Therapeutics, Inc. 165.08 Million USD 86.723%
Kiniksa Pharmaceuticals, Ltd. 526.32 Million USD 95.836%
Ventyx Biosciences, Inc. 277.69 Million USD 92.107%
Allakos Inc. 243.61 Million USD 91.003%
Fulcrum Therapeutics, Inc. 257.69 Million USD 91.495%
Corcept Therapeutics Incorporated 621.51 Million USD 96.473%
BioAtla, Inc. 119.65 Million USD 81.683%
NLS Pharmaceutics AG 1.84 Million USD -1086.916%
Bio-Path Holdings, Inc. 3.22 Million USD -580.685%
Allogene Therapeutics, Inc. 642.83 Million USD 96.59%
Larimar Therapeutics, Inc. 95.93 Million USD 77.153%
XOMA Corporation 234.3 Million USD 90.645%
Kezar Life Sciences, Inc. 221.23 Million USD 90.093%
Cara Therapeutics, Inc. 125.84 Million USD 82.583%
aTyr Pharma, Inc. 122.06 Million USD 82.044%
Aligos Therapeutics, Inc. 153.9 Million USD 85.759%
Akero Therapeutics, Inc. 580.27 Million USD 96.223%
Viridian Therapeutics, Inc. 490.42 Million USD 95.531%
Eliem Therapeutics, Inc. 110.46 Million USD 80.159%
EyeGate Pharmaceuticals, Inc. 15.15 Million USD -44.602%
Akari Therapeutics, Plc 4.35 Million USD -403.285%
Tevogen Bio Holdings Inc. 17.03 Million USD -28.647%
Halozyme Therapeutics, Inc. 1.73 Billion USD 98.735%
Lexaria Bioscience Corp. 3.08 Million USD -610.706%
UroGen Pharma Ltd. 178.31 Million USD 87.708%
Sutro Biopharma, Inc. 470.73 Million USD 95.344%
ZIVO Bioscience, Inc. 555.71 Thousand USD -3844.12%
Orgenesis Inc. 14.55 Million USD -50.619%
Entera Bio Ltd. 11.76 Million USD -86.299%
GH Research PLC 226.3 Million USD 90.315%
Lisata Therapeutics, Inc. 54.69 Million USD 59.926%
Reneo Pharmaceuticals, Inc. 107.43 Million USD 79.599%
Xencor, Inc. 952.69 Million USD 97.699%
60 Degrees Pharmaceuticals, Inc. 7.78 Million USD -181.587%
Replimune Group, Inc. 487.72 Million USD 95.506%
Coeptis Therapeutics Holdings, Inc. 8.07 Million USD -171.563%
Vanda Pharmaceuticals Inc. 648.44 Million USD 96.62%
Lexaria Bioscience Corp. 3.08 Million USD -610.706%
Portage Biotech Inc. 7.77 Million USD -181.759%
Cardio Diagnostics Holdings, Inc. 4.46 Million USD -391.176%
Olema Pharmaceuticals, Inc. 276.94 Million USD 92.086%
OncoCyte Corporation 74.89 Million USD 70.734%
Qualigen Therapeutics, Inc. 2.03 Million USD -977.983%
Processa Pharmaceuticals, Inc. 5.78 Million USD -278.77%
Purple Biotech Ltd. 44.3 Million USD 50.526%
CollPlant Biotechnologies Ltd. 34.12 Million USD 35.773%
scPharmaceuticals Inc. 94.47 Million USD 76.801%
ProMIS Neurosciences, Inc. 18.04 Million USD -21.464%
HilleVax, Inc. 344.43 Million USD 93.636%
NeuroSense Therapeutics Ltd. 3.17 Million USD -590.116%
Tharimmune, Inc. 10.94 Million USD -100.231%
Genprex, Inc. 10.67 Million USD -105.406%
Neumora Therapeutics, Inc. Common Stock 496.19 Million USD 95.583%
Atossa Therapeutics, Inc. 96.25 Million USD 77.228%
XTL Biopharmaceuticals Ltd. 2.42 Million USD -803.465%
Virios Therapeutics, Inc. 4.16 Million USD -426.188%
OKYO Pharma Limited 1.54 Million USD -1322.084%
Savara Inc. 177.56 Million USD 87.656%
Curis, Inc. 77.28 Million USD 71.639%
Daré Bioscience, Inc. 21.28 Million USD -2.988%
Carmell Therapeutics Corporation 63.94 Million USD 65.726%
Titan Pharmaceuticals, Inc. 8.08 Million USD -171.062%
Achieve Life Sciences, Inc. 19.37 Million USD -13.149%
BeiGene, Ltd. 5.8 Billion USD 99.622%
Kiromic BioPharma, Inc. 12.16 Million USD -80.114%
Revolution Medicines, Inc. Warrant 2.08 Billion USD 98.951%
Protagonist Therapeutics, Inc. 357.95 Million USD 93.877%
Erasca, Inc. 395.29 Million USD 94.455%
bluebird bio, Inc. 619.16 Million USD 96.46%
Protagenic Therapeutics, Inc. 4.32 Million USD -406.967%
BioMarin Pharmaceutical Inc. 6.84 Billion USD 99.68%
DBV Technologies S.A. 182.98 Million USD 88.022%
Protagenic Therapeutics, Inc. 4.32 Million USD -406.967%
Moderna, Inc. 18.42 Billion USD 99.881%
Vincerx Pharma, Inc. 18.21 Million USD -20.317%
Fresh Tracks Therapeutics, Inc. 11.58 Million USD -89.177%
Molecular Templates, Inc. 35.38 Million USD 38.055%
Acrivon Therapeutics, Inc. Common Stock 138.26 Million USD 84.148%
Travere Therapeutics, Inc. 788.91 Million USD 97.222%
Monte Rosa Therapeutics, Inc. 303.75 Million USD 92.784%
Spruce Biosciences, Inc. 103.94 Million USD 78.914%
Celldex Therapeutics, Inc. 465.62 Million USD 95.293%
Cogent Biosciences, Inc. 313.43 Million USD 93.007%
MacroGenics, Inc. 306.82 Million USD 92.856%
RenovoRx, Inc. 1.46 Million USD -1395.093%
Adicet Bio, Inc. 207.29 Million USD 89.427%
Prime Medicine, Inc. 193.85 Million USD 88.693%
Aditxt, Inc. 44.57 Million USD 50.832%
Adagene Inc. 115.72 Million USD 81.061%
Estrella Immunopharma, Inc. 4.45 Million USD -392.078%
Quantum-Si incorporated 298.25 Million USD 92.651%
Maravai LifeSciences Holdings, Inc. 1.48 Billion USD 98.526%
Acurx Pharmaceuticals, Inc. 7.7 Million USD -184.313%
Voyager Therapeutics, Inc. 351.28 Million USD 93.761%
SciSparc Ltd. 11.18 Million USD -96.012%
Vericel Corporation 353.65 Million USD 93.802%
Revelation Biosciences, Inc. 12.21 Million USD -79.471%
Minerva Neurosciences, Inc. 56.9 Million USD 61.48%
Generation Bio Co. 374.75 Million USD 94.151%
Astria Therapeutics, Inc. 254.66 Million USD 91.393%
Black Diamond Therapeutics, Inc. 158.56 Million USD 86.177%
Arcutis Biotherapeutics, Inc. 341.36 Million USD 93.579%
Invivyd, Inc. 229.18 Million USD 90.436%
Relay Therapeutics, Inc. 843.98 Million USD 97.403%
Quoin Pharmaceuticals, Ltd. 12.16 Million USD -80.11%
Spero Therapeutics, Inc. 182.39 Million USD 87.983%
Artelo Biosciences, Inc. 20.42 Million USD -7.315%
2seventy bio, Inc. 565.42 Million USD 96.124%
ADMA Biologics, Inc. 329.18 Million USD 93.342%
Clene Inc. 52.34 Million USD 58.124%
Capricor Therapeutics, Inc. 58.73 Million USD 62.683%
Boundless Bio, Inc. Common Stock 129.89 Million USD 83.126%
GeoVax Labs, Inc. 9.28 Million USD -136.104%
Recursion Pharmaceuticals, Inc. 653.69 Million USD 96.647%
Citius Pharmaceuticals, Inc. 103.61 Million USD 78.846%
Contineum Therapeutics, Inc. Class A Common Stock 130.38 Million USD 83.19%
Relmada Therapeutics, Inc. 97.55 Million USD 77.532%
Finch Therapeutics Group, Inc. 70.99 Million USD 69.128%
ALX Oncology Holdings Inc. 242.55 Million USD 90.964%
Vir Biotechnology, Inc. 1.96 Billion USD 98.882%
Evaxion Biotech A/S 12.88 Million USD -70.058%
Ocular Therapeutix, Inc. 252.06 Million USD 91.304%
Verve Therapeutics, Inc. 752.68 Million USD 97.088%
Trevena, Inc. 40.6 Million USD 46.021%
Surrozen, Inc. 46.08 Million USD 52.435%
Tyra Biosciences, Inc. 225.85 Million USD 90.296%
Cingulate Inc. 3.49 Million USD -527.767%
Galmed Pharmaceuticals Ltd. 16.62 Million USD -31.806%
Unity Biotechnology, Inc. 65.69 Million USD 66.634%
Tenax Therapeutics, Inc. 11.68 Million USD -87.58%
Terns Pharmaceuticals, Inc. 268.51 Million USD 91.837%
ACADIA Pharmaceuticals Inc. 748.95 Million USD 97.074%
Connect Biopharma Holdings Limited 125.89 Million USD 82.59%
Clearmind Medicine Inc. 4.32 Million USD -406.848%
Kronos Bio, Inc. 213.27 Million USD 89.723%
Bolt Biotherapeutics, Inc. 159.78 Million USD 86.283%
CERo Therapeutics Holdings, Inc. 8.56 Million USD -156.034%
Viking Therapeutics, Inc. 368.49 Million USD 94.052%
Statera Biopharma, Inc. 21.16 Million USD -3.535%
ImmunityBio, Inc. 504.45 Million USD 95.655%
Korro Bio, Inc. 221.66 Million USD 90.112%
Kineta, Inc. 10.28 Million USD -113.19%
BioVie Inc. 25.2 Million USD 13.052%
Codexis, Inc. 136.56 Million USD 83.95%
Celularity Inc. 143.88 Million USD 84.767%
Crinetics Pharmaceuticals, Inc. 635.35 Million USD 96.55%
Celcuity Inc. 191.21 Million USD 88.538%
Virax Biolabs Group Limited 5.48 Million USD -299.675%
Cibus, Inc. 544.41 Million USD 95.974%
Eledon Pharmaceuticals, Inc. 125.89 Million USD 82.59%
eFFECTOR Therapeutics, Inc. 20.54 Million USD -6.688%
IN8bio, Inc. 33.7 Million USD 34.979%
Kodiak Sciences Inc. 479.37 Million USD 95.428%
Annexon, Inc. 297.67 Million USD 92.637%
Adverum Biotechnologies, Inc. 173.01 Million USD 87.331%
Assembly Biosciences, Inc. 137.46 Million USD 84.056%
Avalo Therapeutics, Inc. 20.99 Million USD -4.407%
Ionis Pharmaceuticals, Inc. 2.99 Billion USD 99.267%
Eyenovia, Inc. 28.77 Million USD 23.841%
Puma Biotechnology, Inc. 230.52 Million USD 90.492%
Conduit Pharmaceuticals Inc. 7.22 Million USD -203.406%
Xilio Therapeutics, Inc. 60.92 Million USD 64.025%
Arcellx, Inc. 825.13 Million USD 97.344%
Cardiff Oncology, Inc. 81.63 Million USD 73.152%
Enanta Pharmaceuticals, Inc. 462.27 Million USD 95.259%
Regulus Therapeutics Inc. 30.75 Million USD 28.722%
Moolec Science SA 24.05 Million USD 8.869%
Acumen Pharmaceuticals, Inc. 310.12 Million USD 92.933%
Geron Corporation 394.07 Million USD 94.438%
LAVA Therapeutics N.V. 101.71 Million USD 78.45%
Royalty Pharma plc 16.38 Billion USD 99.866%
Atea Pharmaceuticals, Inc. 594.96 Million USD 96.316%
Greenwich LifeSciences, Inc. 6.99 Million USD -213.347%
TFF Pharmaceuticals, Inc. 12.02 Million USD -82.236%
Mersana Therapeutics, Inc. 226.06 Million USD 90.304%
Humacyte, Inc. 128.22 Million USD 82.906%
Structure Therapeutics Inc. 482.01 Million USD 95.453%
89bio, Inc. 596.26 Million USD 96.324%
PMV Pharmaceuticals, Inc. 252.15 Million USD 91.308%
Avenue Therapeutics, Inc. 1.85 Million USD -1084.76%
Genelux Corporation 27.89 Million USD 21.421%
Trevi Therapeutics, Inc. 89.4 Million USD 75.484%
Lexicon Pharmaceuticals, Inc. 229.42 Million USD 90.447%
Notable Labs, Ltd. 19.54 Million USD -12.165%
Liquidia Corporation 120.43 Million USD 81.8%
Mustang Bio, Inc. 17.74 Million USD -23.538%
Immunovant, Inc. 666.71 Million USD 96.713%
Quantum-Si incorporated 298.25 Million USD 92.651%
Arbutus Biopharma Corporation 144.4 Million USD 84.821%
DiaMedica Therapeutics Inc. 54.16 Million USD 59.531%
Vera Therapeutics, Inc. 175.54 Million USD 87.514%
Acasti Pharma Inc. 73.3 Million USD 70.098%
MiNK Therapeutics, Inc. 4.55 Million USD -381.474%
Pasithea Therapeutics Corp. 26.11 Million USD 16.077%
Xenon Pharmaceuticals Inc. 964.79 Million USD 97.728%
Elevai Labs, Inc. Common Stock 5.18 Million USD -322.32%
NeuroBo Pharmaceuticals, Inc. 22.78 Million USD 3.788%
Tempest Therapeutics, Inc. 51.6 Million USD 57.526%
Soleno Therapeutics, Inc. 180.69 Million USD 87.87%
PepGen Inc. 143.05 Million USD 84.678%
Moleculin Biotech, Inc. 38.21 Million USD 42.648%
United Therapeutics Corporation 7.16 Billion USD 99.694%
Nuvectis Pharma, Inc. 19.18 Million USD -14.246%
Solid Biosciences Inc. 164.93 Million USD 86.711%
BriaCell Therapeutics Corp. 5.87 Million USD -273.248%
Immuneering Corporation 102.58 Million USD 78.634%
Lixte Biotechnology Holdings, Inc. 4.3 Million USD -408.703%
Silo Pharma, Inc. 7.74 Million USD -182.955%
Belite Bio, Inc 94.64 Million USD 76.841%
XOMA Corporation 234.3 Million USD 90.645%
ARS Pharmaceuticals, Inc. 233.18 Million USD 90.601%
Bionomics Limited 27.64 Million USD 20.728%
Apogee Therapeutics, Inc. 401.4 Million USD 94.54%
Alpha Tau Medical Ltd. 107.38 Million USD 79.59%
uniQure N.V. 831.68 Million USD 97.365%
Cassava Sciences, Inc. 151.66 Million USD 85.548%
Estrella Immunopharma, Inc. 4.45 Million USD -392.078%
Poseida Therapeutics, Inc. 273.88 Million USD 91.997%
Forte Biosciences, Inc. 38.98 Million USD 43.771%
Anebulo Pharmaceuticals, Inc. 4.07 Million USD -438.116%
Enlivex Therapeutics Ltd. 36.83 Million USD 40.49%
Conduit Pharmaceuticals Inc. 7.22 Million USD -203.406%
SeaStar Medical Holding Corporation 3.51 Million USD -523.913%
FibroBiologics, Inc. Common Stock 11.82 Million USD -85.416%
Altimmune, Inc. 210.64 Million USD 89.595%
Amicus Therapeutics, Inc. 777.88 Million USD 97.182%
Alpha Tau Medical Ltd. 107.38 Million USD 79.59%
Compugen Ltd. 121.33 Million USD 81.936%
Peak Bio, Inc. 2.59 Million USD -744.167%
Zevra Therapeutics, Inc. 172.32 Million USD 87.281%
Benitec Biopharma Inc. 52.21 Million USD 58.019%
Spyre Therapeutics, Inc. 341.85 Million USD 93.589%
NKGen Biotech, Inc. Common Stock 34.77 Million USD 36.968%
Zura Bio Limited 100.84 Million USD 78.265%
PolyPid Ltd. 15.37 Million USD -42.584%
Aileron Therapeutics, Inc. 119.28 Million USD 81.626%
NKGen Biotech, Inc. Warrants 34.77 Million USD 36.968%
Instil Bio, Inc. 325.63 Million USD 93.269%
argenx SE 4.54 Billion USD 99.517%
Immunome, Inc. 148.54 Million USD 85.244%
Compass Therapeutics, Inc. 156.87 Million USD 86.028%
Verona Pharma plc 308.12 Million USD 92.887%
enGene Holdings Inc. Warrants 86.95 Million USD 74.795%
Shattuck Labs, Inc. 159.56 Million USD 86.264%
CervoMed Inc. 9.97 Million USD -119.785%
LENZ Therapeutics, Inc. 188.45 Million USD 88.37%
Plus Therapeutics, Inc. 11.38 Million USD -92.466%
Dianthus Therapeutics, Inc. 179.4 Million USD 87.783%
Moolec Science SA 24.05 Million USD 8.869%
Enveric Biosciences, Inc. 6.11 Million USD -258.286%
Inovio Pharmaceuticals, Inc. 172.94 Million USD 87.327%
AnaptysBio, Inc. 452.38 Million USD 95.155%
Design Therapeutics, Inc. 289.64 Million USD 92.433%
Leap Therapeutics, Inc. 72.82 Million USD 69.903%
NeurAxis, Inc. 509.49 Thousand USD -4201.895%
Seelos Therapeutics, Inc. 5.41 Million USD -304.542%
Lumos Pharma, Inc. 40.63 Million USD 46.065%
Achilles Therapeutics plc 161.45 Million USD 86.425%
enGene Holdings Inc. Common Stock 86.95 Million USD 74.795%
180 Life Sciences Corp. 5.25 Million USD -316.735%
Opiant Pharmaceuticals, Inc. 70.42 Million USD 68.879%
CERo Therapeutics Holdings, Inc. 8.56 Million USD -156.034%
Nutriband Inc. 7.51 Million USD -191.574%
ORIC Pharmaceuticals, Inc. 254.68 Million USD 91.394%
CG Oncology, Inc. Common stock 199.3 Million USD 89.003%
Fractyl Health, Inc. Common Stock 76.21 Million USD 71.241%
Rani Therapeutics Holdings, Inc. 57.91 Million USD 62.155%
MoonLake Immunotherapeutics 526.54 Million USD 95.837%
Palisade Bio, Inc. 14.05 Million USD -55.978%
Tourmaline Bio, Inc. 210.29 Million USD 89.577%
Beam Therapeutics Inc. 1.45 Billion USD 98.498%
Neurogene Inc. 222.57 Million USD 90.152%
Mirum Pharmaceuticals, Inc. 646.62 Million USD 96.61%
AEON Biopharma, Inc. 6.84 Million USD -220.206%
CARGO Therapeutics, Inc. Common Stock 453.03 Million USD 95.162%
Sesen Bio, Inc. 189.17 Million USD 88.414%
Enliven Therapeutics, Inc. 271.86 Million USD 91.938%
Kiora Pharmaceuticals, Inc. 13.71 Million USD -59.847%
Iovance Biotherapeutics, Inc. 780.35 Million USD 97.191%
Taysha Gene Therapies, Inc. 266.99 Million USD 91.791%
Athira Pharma, Inc. 160.24 Million USD 86.322%
Vaccinex, Inc. 3.63 Million USD -503.637%
HCW Biologics Inc. 28.51 Million USD 23.131%
XOMA Corporation 234.3 Million USD 90.645%
Nektar Therapeutics 398.03 Million USD 94.493%
Arvinas, Inc. 1.3 Billion USD 98.32%
Tevogen Bio Holdings Inc. 17.03 Million USD -28.647%
Merus N.V. 458.49 Million USD 95.22%
Omega Therapeutics, Inc. 204.36 Million USD 89.275%
Quince Therapeutics, Inc. 180.2 Million USD 87.837%
Rezolute, Inc. 132.73 Million USD 83.488%
Clene Inc. 52.34 Million USD 58.124%
Indaptus Therapeutics, Inc. 14.92 Million USD -46.866%
BeyondSpring Inc. 24.8 Million USD 11.649%
Synlogic, Inc. 75.55 Million USD 70.989%
Allarity Therapeutics, Inc. 11.86 Million USD -84.775%
Phio Pharmaceuticals Corp. 9.36 Million USD -134.067%
Peak Bio, Inc. 2.59 Million USD -744.167%
Werewolf Therapeutics, Inc. 174.83 Million USD 87.463%
Krystal Biotech, Inc. 818.35 Million USD 97.322%
Karyopharm Therapeutics Inc. 240.43 Million USD 90.884%
SpringWorks Therapeutics, Inc. 725.78 Million USD 96.98%
Lipella Pharmaceuticals Inc. 3.57 Million USD -512.72%
MannKind Corporation 475.19 Million USD 95.388%
Ikena Oncology, Inc. 192.09 Million USD 88.59%
Cyclerion Therapeutics, Inc. 13.37 Million USD -63.886%
Gyre Therapeutics, Inc. 116.53 Million USD 81.193%
Gossamer Bio, Inc. 311.91 Million USD 92.973%
CohBar, Inc. 16.36 Million USD -33.927%
Cognition Therapeutics, Inc. 35.16 Million USD 37.667%
NRx Pharmaceuticals, Inc. 7.31 Million USD -199.632%
Legend Biotech Corporation 1.84 Billion USD 98.814%
Mural Oncology plc 301.74 Million USD 92.736%
Biora Therapeutics, Inc. 31.21 Million USD 29.784%
PaxMedica, Inc. Common Stock 5.68 Million USD -285.854%
Disc Medicine, Inc. 367.99 Million USD 94.044%
Champions Oncology, Inc. 26.13 Million USD 16.126%
REGENXBIO Inc. 573.97 Million USD 96.181%
Ensysce Biosciences, Inc. 2.7 Million USD -709.357%
Anavex Life Sciences Corp. 154.38 Million USD 85.803%
Cellectar Biosciences, Inc. 12.07 Million USD -81.507%
Edgewise Therapeutics, Inc. 340.03 Million USD 93.554%
Vaxart, Inc. 91.83 Million USD 76.132%
PharmaCyte Biotech, Inc. 59.9 Million USD 63.411%
Aldeyra Therapeutics, Inc. 148.32 Million USD 85.223%
Cellectis S.A. 334.27 Million USD 93.443%
Longeveron Inc. 12.17 Million USD -79.981%
Repare Therapeutics Inc. 253.9 Million USD 91.367%
Sarepta Therapeutics, Inc. 3.26 Billion USD 99.329%
Inozyme Pharma, Inc. 200.84 Million USD 89.087%
Revolution Medicines, Inc. 2.08 Billion USD 98.951%
Nymox Pharmaceutical Corporation 1.62 Million USD -1248.804%
Third Harmonic Bio, Inc. 277.71 Million USD 92.108%
ArriVent BioPharma, Inc. Common Stock 163.09 Million USD 86.561%
AN2 Therapeutics, Inc. 138.74 Million USD 84.203%
Anixa Biosciences, Inc. 25.52 Million USD 14.121%
Vertex Pharmaceuticals Incorporated 22.73 Billion USD 99.904%
Denali Therapeutics Inc. 1.15 Billion USD 98.101%
Revelation Biosciences, Inc. 12.21 Million USD -79.471%
Veru Inc. 50.59 Million USD 56.68%
Corvus Pharmaceuticals, Inc. 45.55 Million USD 51.884%
Cingulate Inc. 3.49 Million USD -527.767%
Passage Bio, Inc. 150.54 Million USD 85.441%
Context Therapeutics Inc. 16.06 Million USD -36.453%
Exicure, Inc. 11.58 Million USD -89.275%
Day One Biopharmaceuticals, Inc. 376.04 Million USD 94.171%
Oramed Pharmaceuticals Inc. 161.64 Million USD 86.44%
Scinai Immunotherapeutics Ltd. 17.47 Million USD -25.447%
Rhythm Pharmaceuticals, Inc. 332.74 Million USD 93.413%
Nuvalent, Inc. 732.38 Million USD 97.007%
ABVC BioPharma, Inc. 14.94 Million USD -46.667%
Carisma Therapeutics, Inc. 89.55 Million USD 75.525%
Unicycive Therapeutics, Inc. 14.19 Million USD -54.45%
OmniAb, Inc. 401.98 Million USD 94.548%
Anew Medical, Inc. 19.45 Million USD -12.655%
Fennec Pharmaceuticals Inc. 26.72 Million USD 17.991%
Lipocine Inc. 23 Million USD 4.708%
Lexeo Therapeutics, Inc. Common Stock 139.8 Million USD 84.323%
Nautilus Biotechnology, Inc. 305.56 Million USD 92.827%
SAB Biotherapeutics, Inc. 83.94 Million USD 73.889%
G1 Therapeutics, Inc. 121.54 Million USD 81.966%
Bellerophon Therapeutics, Inc. 7.93 Million USD -176.22%
Sage Therapeutics, Inc. 882.27 Million USD 97.516%
Ocugen, Inc. 64.54 Million USD 66.043%
Mind Medicine (MindMed) Inc. 124.54 Million USD 82.401%
Q32 Bio Inc. 306.11 Million USD 92.84%
Brainstorm Cell Therapeutics Inc. 4.2 Million USD -420.867%
Alumis Inc. Common Stock 89.61 Million USD 75.541%
Equillium, Inc. 50.53 Million USD 56.624%
Kyverna Therapeutics, Inc. 75.19 Million USD 70.852%
Coya Therapeutics, Inc. 41.27 Million USD 46.896%
CNS Pharmaceuticals, Inc. 1.7 Million USD -1188.652%
Galera Therapeutics, Inc. 26.14 Million USD 16.154%
Evelo Biosciences, Inc. 64.44 Million USD 65.987%
Comera Life Sciences Holdings, Inc. 3.72 Million USD -488.071%
Dominari Holdings Inc. 57.55 Million USD 61.92%
Edesa Biotech, Inc. 8.89 Million USD -146.535%
vTv Therapeutics Inc. 11.01 Million USD -98.93%
Bio-Techne Corporation 2.81 Billion USD 99.221%
Agios Pharmaceuticals, Inc. 937.11 Million USD 97.661%
Harmony Biosciences Holdings, Inc. 811.44 Million USD 97.299%
Prelude Therapeutics Incorporated 277.66 Million USD 92.106%
Candel Therapeutics, Inc. 41.7 Million USD 47.441%
iTeos Therapeutics, Inc. 667.58 Million USD 96.717%
Nkarta, Inc. 378.88 Million USD 94.215%
BioCardia, Inc. 2.98 Million USD -633.782%
Iterum Therapeutics plc 26.25 Million USD 16.531%